<\/p>\n\n\n\n
IFU of Denmark Government Invests USD 12.5 million in AKS Khan Pharmaceuticals, to expand quality, accessible medicines and diagnostics to 8 million patients annually Nationwide expansion of Bangladesh\u2019 largest retail pharmacy chain to 80 locations, and roll out of over 30 new diagnostics centers. The significant investment from IFU – the Danish Investment Fund for Developing Countries will support AKPL\u2019 vision to increase access to world-class healthcare throughout Bangladesh.
Senior officials including AKS Holdings Chairman AK Samsuddin Khan and IFU Chief Executive Officer (CEO) Lars Bo Bertram were present at the signing ceremony at a star hotel in the capital on Wednesday night.
Improving Bangladesh healthcare, for the People Timely and accurate diagnosis is fundamental to ensuring effective treatment of health conditions and improved human health. Access to quality, authentic medicine is crucial to treating and curing disease, and ensuring quality of life for millions of chronic diseases sufferers across Bangladesh.
The investment from IFU will enable AKPL to reach 8 million patients annually within five years, expanding its ecosystem of pharmacies and diagnostics, and scaling up innovative services including home Xray and ultrasound for vulnerable and elderly patients.
A major component of the growth strategy will focus on increasing the company\u2019s presence beyond the capital Dhaka. This expansion is crucial for ensuring that underserved patients of Bangladesh gain improved access to quality healthcare.
\u201cAccess to healthcare is a vital factor in enhancing a country’s social development. This is why healthcare investment stands as one of the four cornerstones of IFU’s strategy for driving meaningful impact. AKPL’s pharmacy-first primary care model, combined with their comprehensive diagnostic solutions, will extend quality healthcare services to millions more patients. Through this investment, we are committing to a healthier and more prosperous future for Bangladesh. Concurrently, we view this investment as financially robust, promising returns over time. This initiative exemplifies the kind of impact investment that has been IFU’s specialty since 1967 and will continue to be a part of our efforts, contributing to the green transition as well as economic and social development.”
Lars Bo Bertram CEO of IFU<\/p>\n","protected":false},"excerpt":{"rendered":"
IFU of Denmark Government Invests USD 12.5 million in AKS Khan Pharmaceuticals, to expand quality, accessible medicines and diagnostics to 8 million patients annually Nationwide expansion of Bangladesh\u2019 largest retail pharmacy chain to 80 locations, and roll out of over 30 new diagnostics centers. The significant investment from IFU – the Danish Investment Fund for […]<\/p>\n","protected":false},"author":1,"featured_media":4931,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[15,12,5],"tags":[],"class_list":["post-4929","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-bangladesh","category-business","category-news"],"yoast_head":"\n